Target Name: PLIN3
NCBI ID: G10226
Review Report on PLIN3 Target / Biomarker Content of Review Report on PLIN3 Target / Biomarker
PLIN3
Other Name(s): perilipin 3 | MGC2012 | Perilipin-3 (isoform 1) | MPR-binding protein 47 kDa | mannose-6-phosphate receptor-binding protein 1 | M6PRBP1 | Perilipin-3 | Perilipin-3 (isoform 2) | Placental protein 17 | testicular tissue protein Li 114 | MGC11117 | TIP47 | PP17 | Tail-interacting protein, 47 kD | placental protein 17 | Mannose-6-phosphate receptor-binding protein 1 | Cargo selection protein (mannose 6 phosphate receptor binding protein) | Perilipin 3, transcript variant 1 | Testicular tissue protein Li 114 | cargo selection protein TIP47 | PLIN3 variant 1 | PLIN3_HUMAN | 47 kDa MPR-binding protein | PLIN3 variant 2 | Cargo selection protein TIP47 | tail-interacting protein, 47 kD | 47 kDa mannose 6-phosphate receptor-binding protein | Perilipin 3, transcript variant 2 | MPR-BINDING PROTEIN, 47-KD

PLIN3: A Potential Drug Target for Pain Disorders

PLIN3, also known as perilipin-3, is a protein that is expressed in various tissues throughout the body. It is a member of the PIP family, which includes proteins that are involved in the regulation of ion channels and signaling pathways. PLIN3 has been shown to play a role in the regulation of pain signaling, and is Therefore, it is a potential drug target or biomarker for the treatment of pain disorders.

The PIP family of proteins is characterized by the presence of a unique C-terminus domain, which is composed of a series of conserved amino acids that are involved in the formation of a hydrogen bond with other proteins. This domain is also known as the \"perilipin\" domain, and is thought to play a key role in the protein's stability and interactions with other molecules.

PLIN3 is a 12-kDa protein that is expressed in various tissues, including the brain, liver, and muscle. It is primarily localized to the endoplasmic reticulum, where it is involved in the regulation of the levels of various proteins in the cell. PLIN3 has been shown to play a role in the regulation of pain signaling by the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1.

PLIN3 is also involved in the regulation of neurotransmitter signaling pathways, which are critical for the transmission of signals between neurons. It has been shown to interact with the neurotransmitter GABA, which is involved in the regulation of anxiety and other neurological disorders.

In addition to its role in pain and neurotransmitter signaling, PLIN3 is also involved in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die as a result of environmental or genetic stress.

PLIN3 is also a potential biomarker for the diagnosis and monitoring of various diseases, including cancer. It has been shown to be expressed in the brains of patients with various types of cancer, and has been used as a target for small molecule inhibitors that can inhibit its activity.

In conclusion, PLIN3 is a protein that is involved in the regulation of various physiological processes in the body. Its role in pain and neurotransmitter signaling, as well as its involvement in cell survival and proliferation, make it a potential drug target or biomarker for the treatment of pain disorders and other diseases. Further research is needed to fully understand the role of PLIN3 in these processes and to develop effective treatments.

Protein Name: Perilipin 3

Functions: Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets (PubMed:34077757). Required for the transport of mannose 6-phosphate receptors (MPR) from endosomes to the trans-Golgi network (PubMed:9590177)

The "PLIN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLIN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLIN4 | PLIN5 | PLK1 | PLK2 | PLK3 | PLK4 | PLK5 | PLLP | PLN | PLOD1 | PLOD2 | PLOD3 | PLP1 | PLP2 | PLPBP | PLPP1 | PLPP2 | PLPP3 | PLPP4 | PLPP5 | PLPP6 | PLPP7 | PLPPR1 | PLPPR2 | PLPPR3 | PLPPR4 | PLPPR5 | PLPPR5-AS1 | PLRG1 | PLS1 | PLS3 | PLSCR1 | PLSCR2 | PLSCR3 | PLSCR4 | PLSCR5 | PLTP | PLUT | PLVAP | PLXDC1 | PLXDC2 | PLXNA1 | PLXNA2 | PLXNA3 | PLXNA4 | PLXNB1 | PLXNB2 | PLXNB3 | PLXNC1 | PLXND1 | PM20D1 | PM20D2 | PMAIP1 | PMCH | PMCHL1 | PMCHL2 | PMEL | PMEPA1 | PMF1 | PMF1-BGLAP | PMFBP1 | PML | PMM1 | PMM2 | PMP2 | PMP22 | PMPCA | PMPCB | PMS1 | PMS2 | PMS2P1 | PMS2P12 | PMS2P13 | PMS2P2 | PMS2P3 | PMS2P4 | PMS2P5 | PMS2P9 | PMVK | PNCK | PNISR | PNISR-AS1 | PNKD | PNKP | PNKY | PNLDC1 | PNLIP | PNLIPRP1 | PNLIPRP2 | PNLIPRP3 | PNMA1 | PNMA2 | PNMA3 | PNMA5 | PNMA6A | PNMA8A | PNMA8B | PNMT | PNN | PNO1